Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

DANAHER CORPORATION

(DHR)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
326.52(c) 321.64(c) 319.72(c) 316.06(c) 312.94(c) Last
3 088 671 3 342 284 2 344 323 2 881 289 2 891 118 Volume
+0.79% -1.49% -0.60% -1.14% -0.99% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 29 029 M - -
Net income 2021 6 033 M - -
Net Debt 2021 19 545 M - -
P/E ratio 2021 37,7x
Yield 2021 0,29%
Sales 2022 30 714 M - -
Net income 2022 6 303 M - -
Net Debt 2022 13 832 M - -
P/E ratio 2022 36,8x
Yield 2022 0,32%
Capitalization 224 B 224 B -
EV / Sales 2021 8,38x
EV / Sales 2022 7,73x
Nbr of Employees 68 000
Free-Float 74,2%
More Financials
Company
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through three segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies... 
More about the company
Ratings of Danaher Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about DANAHER CORPORATION
12/03Fortive to buy healthcare software maker Provation for $1.43 bln
RE
12/02Danaher Prices $1 Billion Senior Notes Offering
MT
12/01Danaher Announces Pricing Of Senior Notes Offering
PR
12/01Danaher Announces Pricing of Senior Notes Offering
CI
11/30INSIDER SELL : Danaher
MT
11/30IDBS Polar™ Insight Brings Advanced Data Analytics and Visualization to BioPharma..
PR
11/29Danaher to Redeem 800 Million Euros of Senior Notes Due 2025
MT
11/29Danaher Announces Redemption Of Senior Notes
PR
11/29Danaher Corporation Announces Redemption of Senior Notes
CI
11/23Danaher To Present At Evercore ISI HealthCONx Conference
PR
11/22INSIDER SELL : Danaher
MT
11/12INSIDER SELL : Danaher
MT
11/10How GE's Larry Culp split the empire Jack Welch built
RE
11/09FROM EDISON TO WELCH TO CULP : the rise and fall of GE
RE
11/05INSIDER SELL : Danaher
MT
More news
News in other languages on DANAHER CORPORATION
12/03Fortive va racheter le fabricant de logiciels de soins de santé Provation pour 1,43 mil..
12/02Danaher lance une offre d'obligations de premier rang d'un milliard de dollars
11/29Danaher va racheter 800 millions d'euros d'obligations de premier rang à échéance 2025
11/22VENTE D'INITIÉS : Danaher
11/12VENTE D'INITIÉS : Danaher
More news
Analyst Recommendations on DANAHER CORPORATION
More recommendations
Stock Trading Strategies
DANAHER CORPORATION - 11/10
The trend should regain control
BUY
More Stock Trading Analysis
Chart DANAHER CORPORATION
Duration : Period :
Danaher Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DANAHER CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Last Close Price 312,94 $
Average target price 339,17 $
Spread / Average Target 8,38%
EPS Revisions
Managers and Directors
Rainer M. Blair President, Chief Executive Officer & Director
Matthew R. McGrew Chief Financial Officer & Executive Vice President
Steven M. Rales Chairman
Jose Carlos GutiÚrrez Ramos Chief Science Officer & Senior Vice President
Brian W. Ellis Senior Vice President & General Counsel
Sector and Competitors